← The BriefBrief
Event Brief

Evidence questioned for NAD+ longevity claims

Filed: May 11, 2026 at 5:02 PM ET
Summary: Researchers say marketing claims about NAD+ pills and infusions have outpaced scientific evidence.
WHO: Researchers
WHAT: Researchers evaluate and challenge NAD+ marketing claims for longevity.
WHEN: May 11, 2026 at 5:00 AM ET
WHERE: Location not specified
WHY: No specific cause was reported.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.

Know more. Read less.

The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.

Same format. Every time.

See how stories unfold →